STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CNST CONSTELLATION PHARMACEUTICALS INCORPORATED StockScouter® Report

1

StockScouter® Score

CONSTELLATION PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like CNST

 

Concerns

  • The 50-day moving average for CNST is significantly below its 200-day moving average. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for CNST. Negative
  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

C
C
N/A
F

Previous Ratings

4
4
3